Taking people in AustriaPhase 1
Studying how a brain scan tracer moves in healthy adults and people with Alzheimer's
Tests a radioactive tracer, metoclopramide, in healthy adults and people with Alzheimer's disease.
Key facts
- Who runs it
- Medical University Of Vienna
- Where
- Vienna, AustriaSee the site
- Registry title
- A pilot study to assess the impact of ABCB1 on the neuropharmacokinetics of the weak ABCB1 substrate [11C]metoclopramide
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 85 people, planned
- Started
- 12 Oct 2017
- Expected to end
- 1 Jun 2030
- Type of study
- Interventional
- Record updated
- 15 January 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy volunteers and people with dementia due to Alzheimer's disease. It studies how the substance [11C]metoclopramide behaves in the brain.
- Age
- 18 years or older
- Sex
- All sexes can join
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- How old are you?
Where in Austria
- Medical University of ViennaVienna, AustriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Studying how a brain scan tracer moves in healthy adults and people with Alzheimer'sGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Fit questions
- Built from 2024-517875-19-00, who can take part
- Record updated
- 15 January 2025